iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 12-Month High – Here’s What Happened

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) hit a new 52-week high during trading on Thursday. The company traded as high as $109.84 and last traded at $110.3080, with a volume of 14,879 shares trading hands. The stock had previously closed at $109.09.

iShares U.S. Pharmaceuticals ETF Stock Performance

The firm has a 50 day moving average price of $102.48 and a two-hundred day moving average price of $95.27. The company has a market cap of $1.61 billion, a P/E ratio of 17.75 and a beta of 0.47.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in IHE. McElhenny Sheffield Capital Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $13,201,000. Allworth Financial LP grew its position in shares of iShares U.S. Pharmaceuticals ETF by 6.6% during the third quarter. Allworth Financial LP now owns 1,589 shares of the company’s stock worth $157,000 after purchasing an additional 99 shares in the last quarter. Fisher Asset Management LLC purchased a new position in iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth approximately $271,848,000. Russell Investments Group Ltd. boosted its stake in iShares U.S. Pharmaceuticals ETF by 148.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 467 shares of the company’s stock worth $47,000 after purchasing an additional 279 shares during the period. Finally, Fifth Third Bancorp grew its holdings in iShares U.S. Pharmaceuticals ETF by 16.6% during the 3rd quarter. Fifth Third Bancorp now owns 7,898 shares of the company’s stock valued at $794,000 after buying an additional 1,125 shares in the last quarter.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.